CD79A and infection: In breakthrough infection groups, pregnant individuals infected after two doses had higher anti-RBD IgA than those after three doses (9.1-fold, P = 0.02), while there was no significant difference in breakthrough infection after three vaccine doses, in both pregnant and non-pregnant individuals.